China's pharmaceuticals regulation will strengthen
China's scandal-hit pharmaceuticals sector is in for a regulatory shakeup
You must be signed in to read this analysis
In this article
- Two markets
- Reform and opening
- Improving drugs safety
- Vaccine Administration Law
- Drug Administration Law
- Basic Medical, Hygiene and Healthcare Promotion Law
- Institutional changes
- Reducing costs at the hospital level
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.
